{"id":2201,"date":"2026-04-10T08:27:38","date_gmt":"2026-04-10T05:27:38","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/ck-kreatin-kinaz-2\/"},"modified":"2026-04-21T12:38:38","modified_gmt":"2026-04-21T09:38:38","slug":"ck-kreatin-kinaz","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/ck-kreatin-kinaz\/","title":{"rendered":"CK (Kreatin Kinaz)"},"content":{"rendered":"<h1>CK (Kreatin Kinaz)<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO4310<\/li>\n<li><strong>SUT Kodu:<\/strong> L104730<\/li>\n<li><strong>Eski Kod:<\/strong> B\u01300056<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:00<\/li>\n<\/ul>\n<h2>CK (Kreatin Kinaz) Testi Nedir?<\/h2>\n<p>CK (Kreatin Kinaz), laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme \u00e7o\u011fu zaman serum \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<p>CK (Kreatin Kinaz), enerji metabolizmas\u0131nda kreatin fosfat ile ATP aras\u0131ndaki d\u00f6n\u00fc\u015f\u00fcm\u00fc katalize eden bir enzimdir. Ba\u015fl\u0131ca iskelet kas\u0131, kalp kas\u0131 ve beyinde bulunur. \u00dc\u00e7 izoenzim formu vard\u0131r: CK-MM (iskelet kas\u0131), CK-MB (kalp kas\u0131) ve CK-BB (beyin). Kas hasar\u0131 ve miyokard enfarkt\u00fcs\u00fc de\u011ferlendirmesinde \u00f6nemli bir belirte\u00e7tir.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>CK (Kreatin Kinaz) Hangi Durumlarda \u0130stenir?<\/h2>\n<p>CK (Kreatin Kinaz) testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Miyokard enfarkt\u00fcs\u00fc \u015f\u00fcphesi (troponin ile birlikte)<\/li>\n<li>Kas hastal\u0131klar\u0131n\u0131n tan\u0131 ve takibi (miyozit, distrofi)<\/li>\n<li>Rabdomiyoliz tan\u0131 ve izlemi<\/li>\n<li>Statin kaynakl\u0131 kas hasar\u0131n\u0131n takibi<\/li>\n<li>Malign hipertermi \u015f\u00fcphesi<\/li>\n<li>Hipotiroidizm ili\u015fkili miyopati<\/li>\n<li>Egzersize ba\u011fl\u0131 kas hasar\u0131n\u0131n de\u011ferlendirmesi<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>CK (Kreatin Kinaz) Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>A\u00e7l\u0131k genellikle gerekmez.<\/li>\n<li>A\u011f\u0131r egzersiz ve fiziksel aktiviteden testten en az 24\u201348 saat \u00f6nce ka\u00e7\u0131n\u0131lmal\u0131d\u0131r.<\/li>\n<li>\u0130ntram\u00fcsk\u00fcler enjeksiyonlardan ka\u00e7\u0131n\u0131lmal\u0131d\u0131r (CK&#8217;y\u0131 art\u0131r\u0131r).<\/li>\n<li>Kullan\u0131lan ila\u00e7lar (\u00f6zellikle statinler) hekime bildirilmelidir.<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>CK (Kreatin Kinaz) Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>CK (Kreatin Kinaz) testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:00<\/li>\n<\/ul>\n<ul>\n<li><strong>Numune tipi:<\/strong> Ven\u00f6z kan (serum)<\/li>\n<li><strong>Numune al\u0131m\u0131:<\/strong> Koldan ven\u00f6z kan al\u0131n\u0131r.<\/li>\n<li><strong>Y\u00f6ntem:<\/strong> Kinetik UV y\u00f6ntemi (IFCC)<\/li>\n<li><strong>Sonu\u00e7 s\u00fcresi:<\/strong> Genellikle ayn\u0131 g\u00fcn i\u00e7inde sonu\u00e7lan\u0131r.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>CK (Kreatin Kinaz) Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>Ayn\u0131 g\u00fcn 18:00<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Grup<\/th><th>De\u011fer Aral\u0131\u011f\u0131<\/th><\/tr><\/thead><tbody><tr><td>Erkek (yeti\u015fkin)<\/td><td>39\u2013308 U\/L<\/td><\/tr><tr><td>Kad\u0131n (yeti\u015fkin)<\/td><td>26\u2013192 U\/L<\/td><\/tr><tr><td>Yenido\u011fan<\/td><td>Yeti\u015fkin de\u011ferlerinin 2\u20133 kat\u0131 (do\u011fum travmas\u0131 nedeniyle)<\/td><\/tr><tr><td>\u00c7ocuk<\/td><td>Yeti\u015fkin de\u011ferlerine yak\u0131n<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>> Not: Kas k\u00fctlesi y\u00fcksek bireylerde (sporcular) fizyolojik olarak daha y\u00fcksek de\u011ferler g\u00f6r\u00fclebilir. Etnik k\u00f6ken de etkilidir; Afrika k\u00f6kenli bireylerde de\u011ferler daha y\u00fcksek olabilir.<\/p>\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>CK (Kreatin Kinaz) Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<h3>Y\u00fcksek CK<\/h3>\n<p><strong>Kas kaynakl\u0131:<\/strong><\/p>\n<ul>\n<li>Rabdomiyoliz (\u00e7ok y\u00fcksek de\u011ferler, >10.000 U\/L)<\/li>\n<li>Polimiyozit \/ dermatomiyozit<\/li>\n<li>M\u00fcsk\u00fcler distrofiler (Duchenne, Becker)<\/li>\n<li>A\u011f\u0131r egzersiz \/ travma<\/li>\n<li>\u0130ntram\u00fcsk\u00fcler enjeksiyonlar<\/li>\n<li>Malign hipertermi<\/li>\n<li>Status epileptikus (uzam\u0131\u015f n\u00f6betler)<\/li>\n<\/ul>\n<p><strong>Kardiyak kaynakl\u0131:<\/strong><\/p>\n<ul>\n<li>Miyokard enfarkt\u00fcs\u00fc (CK-MB fraksiyonu artar)<\/li>\n<li>Miyokardit<\/li>\n<li>Kardiyak cerrahi sonras\u0131<\/li>\n<\/ul>\n<p><strong>\u0130la\u00e7 kaynakl\u0131:<\/strong><\/p>\n<ul>\n<li>Statinler (miyalji, miyopati, nadiren rabdomiyoliz)<\/li>\n<li>Fibratlar<\/li>\n<li>Kol\u015fisin<\/li>\n<li>Antipsikotikler (n\u00f6roleptik malign sendrom)<\/li>\n<li>Kokain<\/li>\n<\/ul>\n<p><strong>Endokrin:<\/strong><\/p>\n<ul>\n<li>Hipotiroidizm<\/li>\n<li>Addison hastal\u0131\u011f\u0131<\/li>\n<\/ul>\n<p><strong>Di\u011fer:<\/strong><\/p>\n<ul>\n<li>Serebrovask\u00fcler olay (CK-BB)<\/li>\n<li>Elektrik \u00e7arpmas\u0131<\/li>\n<li>Uzun s\u00fcreli immobilizasyon<\/li>\n<\/ul>\n<h3>D\u00fc\u015f\u00fck CK<\/h3>\n<ul>\n<li>D\u00fc\u015f\u00fck kas k\u00fctlesi (ka\u015feksi, ya\u015fl\u0131l\u0131k)<\/li>\n<li>Ba\u011f dokusu hastal\u0131klar\u0131 (romatoid artrit \u2014 baz\u0131 vakalarda)<\/li>\n<li>Alkolik karaci\u011fer hastal\u0131\u011f\u0131<\/li>\n<li>Gebelik (erken d\u00f6nem)<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>CK kas hasar\u0131n\u0131n en duyarl\u0131 g\u00f6stergesidir ancak kayna\u011f\u0131n belirlenmesi i\u00e7in izoenzim analizi (CK-MB) veya troponin gerekir.<\/li>\n<li>A\u011f\u0131r egzersiz sonras\u0131 CK normalin 10 kat\u0131na kadar y\u00fckselebilir; klinik korelasyon \u00f6nemlidir.<\/li>\n<li>Statin kullanan hastalarda kas a\u011fr\u0131s\u0131 ve CK y\u00fcksekli\u011fi yak\u0131ndan izlenmelidir; CK >10 \u00d7 \u00fcst s\u0131n\u0131r ise ila\u00e7 kesilmelidir.<\/li>\n<li>Rabdomiyolizde CK \u00e7ok y\u00fcksek de\u011ferlere ula\u015f\u0131r ve akut b\u00f6brek hasar\u0131 riski vard\u0131r; acil m\u00fcdahale gerekir.<\/li>\n<li>\u0130ntram\u00fcsk\u00fcler enjeksiyonlar CK&#8217;y\u0131 y\u00fckseltir; testten \u00f6nce yap\u0131lmam\u0131\u015f olmal\u0131d\u0131r.<\/li>\n<li>Hemolizli numuneler sonu\u00e7lar\u0131 etkileyebilir.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>CK (Kreatin Kinaz) Laboratuvar Bilgileri Yeni Kod: BIO4310 SUT Kodu: L104730 Eski Kod: B\u01300056 Kategori: Biyokimya Numune T\u00fcr\u00fc: Serum Numune Kab\u0131: Sar\u0131 Kapak \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: Ayn\u0131 g\u00fcn 18:00 CK (Kreatin Kinaz) Testi Nedir? CK (Kreatin Kinaz), laboratuvar [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO4310","numune_turu":"Serum","numune_kabi":"Sar\u0131 Kapak","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"Ayn\u0131 g\u00fcn 18:00","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"L104730","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-2201","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=2201"}],"version-history":[{"count":5,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2201\/revisions"}],"predecessor-version":[{"id":8920,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2201\/revisions\/8920"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=2201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}